Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Mancone

Showing results (191-200 of 287) with videos related to

Pageof 29
Sort By:
International Journal of Cardiology|October 24, 2021
New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulationLuca Di Lullo, Carlo Lavalle, Michele Magnocavallo, et al.
Giornale Italiano Di Cardiologia (2006)|March 28, 2022
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials]Pasquale Perrone Filardi, Stefania Paolillo, Ciro Indolfi, et al.
European Journal of Internal Medicine|April 26, 2022
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of CardiologyPasquale Perrone-Filardi, Stefania Paolillo, Piergiuseppe Agostoni, et al.
European Journal of Clinical Investigation|February 24, 2024
Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta-analysisOvidio De Filippo, Gianluca Di Pietro, Marco Nebiolo, et al.
International Journal of Molecular Sciences|May 13, 2023
Protection against Ischemic Heart Disease: A Joint Role for eNOS and the K<sub>ATP</sub> ChannelPaolo Severino, Andrea D'Amato, Massimo Mancone, et al.
The American Journal of Medicine|September 19, 2024
Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort StudyPatrizia Pasculli, Maria Antonella Zingaropoli, Federica Dominelli, et al.
International Journal of Molecular Sciences|November 9, 2024
Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Different Scenarios of Heart Failure: An Overview of the Current LiteratureSilvia Prosperi, Andrea D'Amato, Aurora Labbro Francia, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 27, 2024
Percutaneous coronary intervention versus coronary artery bypass grafting for left main disease according to age: A meta-analysisOvidio De Filippo, Antonino Di Franco, Riccardo Improta, et al.
The American Journal of Cardiology|September 29, 2020
Mortality Risk Assessment Using CHA(2)DS(2)-VASc Scores in Patients Hospitalized With Coronavirus Disease 2019 InfectionGaetano Ruocco, Peter A McCullough, Kristen M Tecson, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2025
Early SGLT2i Therapy Facilitates In-Hospital ARNI Introduction Improving 6-Month Systolic Function in Patients with HFrEFAndrea D'Amato, Silvia Prosperi, Federico Ferranti, et al.
Pageof 29

Showing results (191-200 of 287) with videos related to

Sort By:
Pageof 29
International Journal of Cardiology|October 24, 2021
New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulationLuca Di Lullo, Carlo Lavalle, Michele Magnocavallo, et al.
Giornale Italiano Di Cardiologia (2006)|March 28, 2022
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials]Pasquale Perrone Filardi, Stefania Paolillo, Ciro Indolfi, et al.
European Journal of Internal Medicine|April 26, 2022
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of CardiologyPasquale Perrone-Filardi, Stefania Paolillo, Piergiuseppe Agostoni, et al.
European Journal of Clinical Investigation|February 24, 2024
Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta-analysisOvidio De Filippo, Gianluca Di Pietro, Marco Nebiolo, et al.
International Journal of Molecular Sciences|May 13, 2023
Protection against Ischemic Heart Disease: A Joint Role for eNOS and the K<sub>ATP</sub> ChannelPaolo Severino, Andrea D'Amato, Massimo Mancone, et al.
The American Journal of Medicine|September 19, 2024
Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort StudyPatrizia Pasculli, Maria Antonella Zingaropoli, Federica Dominelli, et al.
International Journal of Molecular Sciences|November 9, 2024
Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Different Scenarios of Heart Failure: An Overview of the Current LiteratureSilvia Prosperi, Andrea D'Amato, Aurora Labbro Francia, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 27, 2024
Percutaneous coronary intervention versus coronary artery bypass grafting for left main disease according to age: A meta-analysisOvidio De Filippo, Antonino Di Franco, Riccardo Improta, et al.
The American Journal of Cardiology|September 29, 2020
Mortality Risk Assessment Using CHA(2)DS(2)-VASc Scores in Patients Hospitalized With Coronavirus Disease 2019 InfectionGaetano Ruocco, Peter A McCullough, Kristen M Tecson, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2025
Early SGLT2i Therapy Facilitates In-Hospital ARNI Introduction Improving 6-Month Systolic Function in Patients with HFrEFAndrea D'Amato, Silvia Prosperi, Federico Ferranti, et al.
Pageof 29